Position
Chief Scientific Officer
Company
Harrow
NashvilleBiotechnologyHealthcareHealth CarePharmaceuticalDescription
Harrow, a leading North American eyecare pharmaceutical company, has announced the appointment of Amir H. Shojaei, PharmD, PhD, as its new Chief Scientific Officer. Dr Shojaei brings with him a remarkable career spanning 28 years in life sciences, with deep expertise in clinical development, regulatory affairs, and the commercialization of biopharmaceutical and biologic products, including groundbreaking work in anterior and posterior segment ophthalmic indications.
Quick answer
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer (January 7, 2025). Harrow is based in Nashville, Tennessee, United States.
- Who is the new Chief Scientific Officer at Harrow?
- Harrow named Amir H. Shojaei Chief Scientific Officer, announced January 7, 2025.
- What did Harrow announce on January 7, 2025?
- Harrow, a leading North American eyecare pharmaceutical company, has announced the appointment of Amir H. Shojaei, PharmD, PhD, as its new Chief Scientific Officer. Dr Shojaei brings with him a remarkable career spanning 28 years in life sciences, with deep expertise in clinical development, regulatory affairs, and the commercialization of biopharmaceutical and biologic products, including groundbreaking work in...
- What does Harrow do?
- Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market, dedicated to innovation and providing affordable, accessible medications.
- Where is Harrow based?
- Harrow is based in Nashville, Tennessee, United States.
- Which similar companies made leadership changes around the same time?
- Amylyx Pharmaceuticals (January 6, 2025), Tarsier Pharma (January 7, 2025), BlossomHill Therapeutics (January 6, 2025) and Centessa Pharmaceuticals plc (January 8, 2025) also announced leadership changes within 45 days of Harrow.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer (January 6, 2025)
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
- BlossomHill Therapeutics Appoints Geoff Oxnard as Chief Medical Officer and Executive Vice President, and Ashley Preston as Senior Vice President and Head of Regulatory Affairs and Quality Assurance (January 6, 2025)
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- TriSalus Appoints James (Jim) Young as Chief Financial Officer and Announces Promotions for Dr. Richard B. Marshak and Jodi Devlin (January 8, 2025)
- Nimbus Therapeutics appoints Peter J. Tummino, Ph.D. as President of Research and Development (January 9, 2025)
Who to call at Harrow, and when
A new leader at Harrow brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Harrow raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Harrow, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Harrow. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Harrow changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Harrow changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.